Patents by Inventor Aruni Bhatnagar

Aruni Bhatnagar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF CONTROLLING MYOCARDIAL BLOOD FLOW
    Publication number: 20240091175
    Abstract: In certain embodiments, the present invention provides a method of modulating myocardial blood flow (MBF) as compared to a control in a patient in need thereof, comprising administering an agent that interacts with a Kv? protein.
    Type: Application
    Filed: September 20, 2023
    Publication date: March 21, 2024
    Applicant: UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, INC.
    Inventors: Matthew Nystoriak, Aruni Bhatnagar
  • METHODS OF CONTROLLING MYOCARDIAL BLOOD FLOW
    Publication number: 20220226265
    Abstract: In certain embodiments, the present invention provides a method of modulating myocardial blood flow (MBF) as compared to a control in a patient in need thereof, comprising administering an agent that interacts with a Kv? protein.
    Type: Application
    Filed: January 18, 2022
    Publication date: July 21, 2022
    Applicant: UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, INC.
    Inventors: Matthew Nystoriak, Aruni Bhatnagar
  • Methods involving aldose reductase inhibitors
    Publication number: 20060293265
    Abstract: Embodiments of the invention include methods and compositions involving aldose reductase inhibitors for the treatment of sepsis and autoimmune diseases, including Type I diabetes and rheumatoid arthritis. The invention also pertains to preventing the loss of cardiac muscle contractibility.
    Type: Application
    Filed: August 23, 2005
    Publication date: December 28, 2006
    Inventors: Satish Srivastava, K. Ramana, Aruni Bhatnagar
  • Methods and compositions involving aldose reductase
    Publication number: 20060210651
    Abstract: Embodiments of the invention include methods and compositions for the inhibition of Aldose Reductase by nitric oxide. Certain embodiments of the invention include the induction of nitric oxide by administration of a nitric oxide donor, nitric oxide precursor, inhibitor of a nitric oxide synthase inhibitor, and/or an activator of nitric oxide synthase. Methods may include the treatment of various disease states by inhibiting Aldose Reductase.
    Type: Application
    Filed: February 28, 2006
    Publication date: September 21, 2006
    Inventors: Satish Srivastava, K. Ramana, Aruni Bhatnagar
  • Methods and compositions involving aldose reductase inhibitors
    Publication number: 20040047919
    Abstract: Embodiments of the invention include methods and compositions for the inhibition of Aldose Reductase by nitric oxide. Certain embodiments of the invention include the induction of nitric oxide by administration of a nitric oxide donor, nitric oxide precursor, inhibitor of a nitric oxide synthase inhibitor, and/or an activator of nitric oxide synthase. Methods may include the treatment of various disease states by inhibiting Aldose Reductase.
    Type: Application
    Filed: June 13, 2003
    Publication date: March 11, 2004
    Applicant: Board of Regents, The University of Texas System
    Inventors: Satish K. Srivastava, K. Venkat Ramana, Aruni Bhatnagar